NCT06481800

Brief Summary

Progressive muscle relaxation versus manual lymphatic drainage on restless leg syndrome and sleep quality in hemodialysis patients

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 15, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 25, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 1, 2024

Completed
19 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 20, 2024

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 21, 2024

Completed
Last Updated

July 26, 2024

Status Verified

July 1, 2024

Enrollment Period

3 months

First QC Date

June 25, 2024

Last Update Submit

July 25, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • International restless legs syndrome rating scale (IRLS)

    It consists of 10 questions considering different aspects of the impact of RLS on a patient's life. Each question can be answered with a Likert-type scale ranging from "none" (0) to "very severe" (4).

    base line and 12 weeks.

  • Pittsburgh Sleep Quality Index (PSQI)

    It is a self-report questionnaire that assesses sleep quality. The patient asked to rate his/ her sleep quality

    base line and 12 weeks

Secondary Outcomes (2)

  • Leg cramps severity scale

    base line and 12 weeks

  • Patient Health Questionnaire (PHQ-9)

    base line and 12 weeks

Study Arms (3)

Group (A):Progressive muscle relaxation (PMR)

EXPERIMENTAL

patients receive progressive muscle relaxation (PMR) for 20 minutes after each dialysis session during the first 2 hours the dialysis treatment with routine medical care for dialysis patients

Other: Progressive muscle relaxation (PMR)

Group (B): Manual lymphatic drainage (MLD)

EXPERIMENTAL

patients receive Manual lymphatic drainage (MLD) for 20 minutes within after each dialysis session during the first 2 hours the dialysis treatment with routine medical care for dialysis patients.

Other: Manual lymphatic drainage (MLD)

Group (C):control

ACTIVE COMPARATOR

patients receive routine medical care for dialysis patients. Routine medical care for RLS and sleep quality in hemodialysis Anemia management, electrolyte balance,Avoiding caffeine and alcohol, establishing a regular sleep schedule leg care,Medicines that increase dopamine in the brain, affecting calcium channels, Opioids , Gabapentin and Pregabali , Benzodiazepines

Other: cnotrol group

Interventions

patients receive progressive muscle relaxation (PMR) for 20 minutes after each dialysis session during the first 2 hours the dialysis treatment with routine medical care for dialysis patients

Group (A):Progressive muscle relaxation (PMR)

Routine medical care for RLS and sleep quality in hemodialysis Anemia management, electrolyte balance,Avoiding caffeine and alcohol, establishing a regular sleep schedule leg care,Medicines that increase dopamine in the brain, affecting calcium channels, Opioids , Gabapentin and Pregabali , Benzodiazepines,Regular monitoring of kidney function, blood tests

Group (C):control

Manual lymphatic drainage (MLD) for 20 minutes within after each dialysis session during the first 2 hours the dialysis treatment with routine medical care for dialysis patients

Group (B): Manual lymphatic drainage (MLD)

Eligibility Criteria

Age35 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male and female adults ranging from 35- 65 years old.
  • Able to communicate verbally and agree to participate in the study.
  • On maintenance arteriovenous fistula (AVF) hemodialysis 3 times weekly.
  • None of the research participants had a lower extremity dialysis graft, and they were all taking medication to maintain their health.
  • Prior to the study procedure, all patients underwent a nephrologist assessment
  • All patients had good compliance with their dialysis treatment (not missing more than 2 dialysis sessions in the prior 3 months

You may not qualify if:

  • Peripheral neuropathy or vascular diseases of the lower limbs.
  • Skin diseases including acute psoriasis or eczema.
  • Recent fractures or lower limbs surgeries.
  • Feet injuries including severe muscle weakness, bruises, ulcers, Open wounds or recent burns

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ahmed Mohamed Ahmed Abdelhady

Cairo, Egypt

Location

Related Links

MeSH Terms

Interventions

Autogenic TrainingManual Lymphatic Drainage

Intervention Hierarchy (Ancestors)

HypnosisMind-Body TherapiesComplementary TherapiesTherapeuticsPsychotherapyBehavioral Disciplines and ActivitiesMassageTherapy, Soft TissueMusculoskeletal ManipulationsDrainagePhysical Therapy ModalitiesRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled trial. To assign patients to different treatment groups, a table of random numbers generated by a computer will be used. Patients will be allocated randomly into three groups using this method
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lectrurer of physical therapy for general surgery and dermatology

Study Record Dates

First Submitted

June 25, 2024

First Posted

July 1, 2024

Study Start

April 15, 2024

Primary Completion

July 20, 2024

Study Completion

July 21, 2024

Last Updated

July 26, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations